[go: up one dir, main page]

UA94010U - Method for treating adenomyosis in women - Google Patents

Method for treating adenomyosis in women

Info

Publication number
UA94010U
UA94010U UAU201404815U UAU201404815U UA94010U UA 94010 U UA94010 U UA 94010U UA U201404815 U UAU201404815 U UA U201404815U UA U201404815 U UAU201404815 U UA U201404815U UA 94010 U UA94010 U UA 94010U
Authority
UA
Ukraine
Prior art keywords
days
dose
therapy
cover
women
Prior art date
Application number
UAU201404815U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Мекан Рахімбердиєвич Оразов
Андрій Володимирович Чайка
Олена Миколаївна Носенко
Original Assignee
Донецький Національний Медичний Університет Ім. М. Горького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донецький Національний Медичний Університет Ім. М. Горького filed Critical Донецький Національний Медичний Університет Ім. М. Горького
Priority to UAU201404815U priority Critical patent/UA94010U/en
Publication of UA94010U publication Critical patent/UA94010U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for treating adenomyosis in women by assigning a course of intramuscular and subcutaneous injections of a minimum therapeutic dose of gonadotropin-releasing hormone agonist in a deposit formulation once per 28 days, with parallel application of “cover” therapy. Moreover, the injections of the gonadotropin-releasing hormone agonist are administered within 6 months, while as a "cover" therapy it is prescribed to administer orally Abyufen for 5-10 days three times a day at a dose 400 mg, Tivortin for 14 days three times a day at a dose of 1 g and a calcium and vitamin D3-based drug for 14 days at a dose of 1500 mg of calcium and 600 IU of vitamin D3; after a two-week break, the course of therapy "cover" is repeated.
UAU201404815U 2014-05-05 2014-05-05 Method for treating adenomyosis in women UA94010U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201404815U UA94010U (en) 2014-05-05 2014-05-05 Method for treating adenomyosis in women

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201404815U UA94010U (en) 2014-05-05 2014-05-05 Method for treating adenomyosis in women

Publications (1)

Publication Number Publication Date
UA94010U true UA94010U (en) 2014-10-27

Family

ID=56285381

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201404815U UA94010U (en) 2014-05-05 2014-05-05 Method for treating adenomyosis in women

Country Status (1)

Country Link
UA (1) UA94010U (en)

Similar Documents

Publication Publication Date Title
MX2021004821A (en) Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy.
MX2022003072A (en) Use of pridopidine for treating functional decline.
MX2017005875A (en) Methods for treating ocular diseases.
JO3784B1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
MX2017006938A (en) Combination therapy for treatment of cancer.
MX390570B (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS THAT INCLUDES INTERLEUKIN 31 ANTAGONIST (IL-31) AS AN ACTIVE INGREDIENT.
ZA202000028B (en) Use of vibegron to treat overactive bladder
MX381440B (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS.
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
MY204827A (en) Semaglutide in medical therapy
MX2023007826A (en) Methods comprising fixed intermittent dosing of cediranib.
MX2020007222A (en) Minocycline for treating inflammatory skin conditions.
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
UA94010U (en) Method for treating adenomyosis in women
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
MX2017006205A (en) Treatment of enteral feeding intolerance.
NZ760033A (en) Methods to treat opioid use disorder
UA95834U (en) Method for treating acute ischemic stroke
BR112018002433A2 (en) pharmaceutical composition for migraine treatment
IL283422A (en) Methods for treating or preventing asthma by administering an il-4r antagonist
EA201590760A1 (en) BREMELANOTIDA APPLICATION IN THE THERAPY OF FEMALE SEXUAL DYSFUNCTION
UA115063U (en) METHOD OF TREATMENT OF DOGS WITH PAIN SYNDROME IN PANCREATITIS
UA99549U (en) Method for treating symptoms of fatigue in multiple sclerosis
UA95037U (en) METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS
UA112502C2 (en) METHOD OF TREATMENT OF ASSOCIATED Gastrointestinal Diseases of Piglets Accompanied by Diarrhea and Multisystemic Expression